The Western Europe nuclear imaging systems market size is expected to reach US$ 1,254.5 million by 2031 from US$ 1,012.1 million in 2024. The market is estimated to record a CAGR of 3.1% from 2025 to 2031.
Executive Summary and Western Europe Nuclear Imaging Systems Market Analysis:
Western Europe has a well-established and mature nuclear imaging market, but the adoption of such advance imaging technique varies across countries. Germany leads in this space with solid infrastructure, a mature manufacturing ecosystem, and a wide integration of nuclear imaging in clinical practice. France, Italy, and Spain are also aggressively developing their imaging capabilities and addressing gaps in scale and technology.
The demand for hybrid imaging systems grows accordingly, especially for PET/CT and SPECT/CT, primarily in oncology and neurology applications where accurate diagnosis is critical. Public hospitals are beginning to adopt more digital platforms that can enable AI-assisted diagnosis and improve management of patient care, although the pattern of implementation is still fragmented across the region. Academic institutions and research centers have been instrumental through combined efforts towards the development of radiopharmaceuticals and in facilitating clinical trials. As there is a growing trend towards outpatient imaging centers coupled with increasing interest in personalized medicine, nuclear imaging will have greater place in modern healthcare—anchored mainly in Germany’s clinical practice and research innovation.
Western Europe Nuclear Imaging Systems Market Segmentation Analysis:
Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.
- By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
- By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.
Western Europe Nuclear Imaging Systems Market Outlook
The nuclear imaging market in Western Europe is steadily expanding, ensuring the osteogenic focus on diagnostic accuracy and coordinated care. The hybrid imaging platforms is being adopted by hospitals and specialty centers to alleviate clinical workflow and systematize treatment planning. Germany is foremost in this trend, investing in AI-powered models to sharpen diagnostic accuracy and obviate reporting lag by deploying diagnostic systems in both public hospitals and private clinics. These diagnostic models support physicians to be more efficient in their decisions, consequently impacting patient care. Germany's manufacturing base is allowing for the continuous advancement of high-resolution detectors and radiotracers, enhanced through both the public and private sectors, to support nuclear imaging in oncology, cardiology, and neurology. Harmonized regulations and multinational research projects will accelerate developer adoption and catalyze the validation of new technologies. As healthcare provides evolve, and seek to maximize resources and efficiencies occur, nuclear imaging continues to coalesce around the changing medical environment in Western Europe.
Western Europe Nuclear Imaging Systems Market Country Insights
Based on country, the Western Europe nuclear imaging systems market is further segmented into Belgium, the Netherlands, Luxembourg, Germany, France, Italy, Spain, Switzerland, Sweden, Austria, the United Kingdom, Denmark, Portugal, Norway, and Finland. Germany held the largest share in 2024.
Germany dominates the nuclear imaging systems market in Western Europe as the country has clinical expertise and highly developed healthcare system. Majority of the hospitals and research institutions in Germany have PET/MRI and SPECT/CT systems for advanced diagnostic capabilities in oncology and neurology. Manufacturers collaborate closely with academic institutions to develop better detectors, radiopharmaceuticals, and improved precision and applications. AI imaging platforms are being introduced across hospital networks, shown to streamline workflows and help in real-time decision-making. Regulatory agencies have introduced efficient approval pathways in place for innovative devices, and this has stimulated entry to the market and deployment of technologies. Germany's focus on quality care and data driven diagnostic approaches also reinforces a sustainable investment in nuclear imaging infrastructure. Education and training programs in nuclear medicine are well established and produce a capable workforce to manage advanced imaging systems. The robust scale, innovation capacity and policy support will maintain Germany's leadership in developed nuclear imaging adoption and development in Western Europe.
Western Europe Nuclear Imaging Systems Market Company Profiles
GE HealthCare, Siemens Healthineers AG, Canon Inc., Koninklijke Philips N.V., SHIMADZU CORPORATION, United Imaging Healthcare Co., Ltd., Neusoft Medical Systems Co., Ltd., Mediso Ltd., Positron Corporation, and MiE GmbH are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
Western Europe Nuclear Imaging Systems Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Key Sources Referred:
- The World Bank
- World Health Organization (WHO)
- Center for Disease Control and Prevention (CDC)
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- European Association of Nuclear Medicine (EANM)
- American College of Nuclear Medicine (ACNM)
- American Society of Nuclear Cardiology (ASNC)
- Global Cancer Observatory
- Company website
- Company annual reports
- Company investor presentations
Western Europe Nuclear Imaging Systems Market Strategic Insights
Western Europe Nuclear Imaging SystemsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 1,012.1 Million |
| Market Size by 2031 | US$ 1,254.5 Million |
| CAGR (2025 - 2031) | 3.1% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Western Europe | Belgium, Netherlands, Luxembourg, Germany, France, Italy, Spain, Switzerland, Sweden, Austria, United Kingdom, Denmark, Portugal, Norway, Finland |
| Market leaders and key company profiles |
|
Western Europe Nuclear Imaging Systems Market Country and Regional Insights
